{"entity":{"id":"nct02662634","kind":"trial","name":"A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer","aka":[],"tldr":"A phase 2 trial of Rocapuldencel-T run by GU Research Network, LLC, withdrawn before enrolling.","summary":"A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer is a phase 2 interventional study registered as NCT02662634 by GU Research Network, LLC, started 2016-03. Conditions recorded: Non-small Cell Lung Cancer (NSCLC). Interventions recorded: AGS-003-LNG, Carboplatin, Abraxane, Alimta, Cisplatin, Taxol and Radiation Therapy.","status":"withdrawn","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02662634","url":"https://clinicaltrials.gov/study/NCT02662634"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["rocapuldencel-t"],"companies":["argos-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02662634","phase":"2","setting":"A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer","sponsor":"GU Research Network, LLC","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02662634/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"rocapuldencel-t","kind":"drug","name":"Rocapuldencel-T","route":"/drugs/rocapuldencel-t/"}],"company":[{"id":"argos-therapeutics","kind":"company","name":"Argos Therapeutics","route":"/companies/argos-therapeutics/"}]}}